Dx Development Solutions

Next Generation Sequencing (NGS) is not the future, it is the present. Every day a new test, a new indication and new data are changing the landscape for diagnosis and treatment in oncology. NGS is in the clinic, but there is a need for more.

Innovation & Quality

Pillar Biosciences is innovating in the space by actively developing NGS based in vitro diagnostics that can be used from the largest reference labs to a one man pathology practice. By focusing on quality and accuracy, then tying performance to regulatory approval, Pillar's On Target IVD will be a solution that can be run anywhere and by any lab with confidence.